DE HB263 | 2019-2020 | 150th General Assembly
Status
Completed Legislative Action
Spectrum: Strong Partisan Bill (Democrat 29-2)
Status: Passed on July 16 2020 - 100% progression
Action: 2020-07-16 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Strong Partisan Bill (Democrat 29-2)
Status: Passed on July 16 2020 - 100% progression
Action: 2020-07-16 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
Title
An Act To Amend Title 18 And Title 29 Of The Delaware Code Relating To Cost Sharing In Prescription Insulin Drugs.
Sponsors
Roll Calls
2020-06-16 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2020-01-30 - House - House Third Reading (Y: 40 N: 0 NV: 0 Abs: 1) [PASS]
2020-01-30 - House - House Third Reading (Y: 40 N: 0 NV: 0 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2020-07-16 | Signed by Governor | |
| 2020-06-16 | Suspension of Rules in Senate | |
| 2020-06-16 | Passed By Senate. Votes: 21 YES | |
| 2020-02-28 | Assigned to Health & Social Services Committee in Senate | |
| 2020-01-30 | Passed By House. Votes: 40 YES 1 ABSENT | |
| 2020-01-30 | Amendment HA 2 to HB 263 - Stricken in House | |
| 2020-01-30 | Amendment HA 1 to HB 263 - Passed In House by Voice Vote | |
| 2020-01-29 | Amendment HA 2 to HB 263 - Introduced and Placed With Bill | |
| 2020-01-29 | Amendment HA 1 to HB 263 - Introduced and Placed With Bill | |
| 2020-01-15 | Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 4 On Its Merits | |
| 2020-01-09 | Introduced and Assigned to Health & Human Development Committee in House |
